China National Medicines Corporation Ltd.’s Net Profit Rose 24.9% in First Quarter of 2022

China National Medicines Corporation Ltd. (国药集团药业股份有限公司) (600511.SH) reported a net profit of 409.5 million yuan in the first quarter of 2022, up 24.9% year-on-year.

Meanwhile, the company posted 11.1 billion yuan in revenue, up 6.9% year-on-year.

At the end of the reporting period, it had 27.4 billion yuan in total assets and 12.6 billion yuan in total liabilities, with a liability-to-asset ratio of 46.1%.